• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新合成喹唑啉衍生物的分子对接及抗惊厥活性

Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives.

作者信息

Abuelizz Hatem A, Dib Rabab El, Marzouk Mohamed, Anouar El-Hassane, A Maklad Yousreya, N Attia Hanan, Al-Salahi Rashad

机构信息

Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11495, Saudi Arabia.

出版信息

Molecules. 2017 Jun 30;22(7):1094. doi: 10.3390/molecules22071094.

DOI:10.3390/molecules22071094
PMID:28665338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6152033/
Abstract

A new series of quinazoline-4(3H)-ones are evaluated for anticonvulsant activity. After intraperitoneal (ip) injection to albino mice at a dose of 100 mg/kg body weight, synthesized quinazolin-4(3H)-ones (1-24) were examined in the maximal electroshock (MES) induced seizures and subcutaneous pentylenetetrazole (scPTZ) induced seizure models in mice. The Rotarod method was applied to determine the neurotoxicity. Most of the compounds displayed anticonvulsant activity in the scPTZ screen at a dose range of 0.204-0.376 mmol/mL. Out of twenty-four, compounds 8, 13 and 19 proved to be the most active with a remarkable protection (100%) against PTZ induced convulsions and four times more potent activity than ethosuximide. The structure-activity relationship concluded valuable pharmacophoric information, which was confirmed by the molecular docking studies using the target enzyme human carbon anhydrase II (HCA II). The studied quinazoline analogues suggested that the butyl substitution at position 3 has a significant effect on preventing the spread of seizure discharge and on raising the seizure threshold. However, benzyl substitution at position 3 has shown a strong anticonvulsant activity but with less seizure prevention compared to the butyl substitution.

摘要

对一系列新型喹唑啉 - 4(3H)-酮进行抗惊厥活性评估。以100 mg/kg体重的剂量腹腔注射给白化小鼠后,在小鼠最大电休克(MES)诱导的癫痫发作和皮下注射戊四氮(scPTZ)诱导的癫痫发作模型中检测合成的喹唑啉 - 4(3H)-酮(1 - 24)。采用转棒试验法测定神经毒性。大多数化合物在0.204 - 0.376 mmol/mL的剂量范围内,在scPTZ筛选中表现出抗惊厥活性。在这24种化合物中,化合物8、13和19被证明活性最强,对PTZ诱导的惊厥具有显著保护作用(100%),且活性比乙琥胺强四倍。构效关系得出了有价值的药效团信息,这通过使用靶酶人碳酸酐酶II(HCA II)的分子对接研究得到了证实。所研究的喹唑啉类似物表明,3位的丁基取代对阻止癫痫放电扩散和提高癫痫阈值有显著影响。然而,3位的苄基取代显示出较强的抗惊厥活性,但与丁基取代相比,预防癫痫发作的效果较差。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/8eeaef04194a/molecules-22-01094-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/5ea6d5679149/molecules-22-01094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/a64869238352/molecules-22-01094-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/33f29e6b892e/molecules-22-01094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/7ff5abb71b59/molecules-22-01094-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/47c98a79da0d/molecules-22-01094-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/8eeaef04194a/molecules-22-01094-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/5ea6d5679149/molecules-22-01094-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/a64869238352/molecules-22-01094-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/33f29e6b892e/molecules-22-01094-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/7ff5abb71b59/molecules-22-01094-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/47c98a79da0d/molecules-22-01094-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb6/6152033/8eeaef04194a/molecules-22-01094-g005a.jpg

相似文献

1
Molecular Docking and Anticonvulsant Activity of Newly Synthesized Quinazoline Derivatives.新合成喹唑啉衍生物的分子对接及抗惊厥活性
Molecules. 2017 Jun 30;22(7):1094. doi: 10.3390/molecules22071094.
2
Structural Exploration of Quinazolin-4(3H)-ones as Anticonvulsants: Rational Design, Synthesis, Pharmacological Evaluation, and Molecular Docking Studies.喹唑啉-4(3H)-酮类化合物作为抗惊厥剂的结构探索:合理设计、合成、药理学评价及分子对接研究
Arch Pharm (Weinheim). 2016 Nov;349(11):864-880. doi: 10.1002/ardp.201600218. Epub 2016 Sep 28.
3
Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor.新型喹唑啉的合成、建模及抗惊厥研究:三种具有低毒性和对GABA-A受体高亲和力的高活性化合物
Molecules. 2017 Jan 24;22(2):188. doi: 10.3390/molecules22020188.
4
Synthesis, Molecular Docking and Evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1, 3] oxazin/thiazin-6-yl} 2-phenyl-3H-quinazolin-4-one Derivatives for their Anticonvulsant Activity.3-{4-[2-氨基-4-(取代苯基)-2H-[1,3]恶嗪/噻嗪-6-基]}2-苯基-3H-喹唑啉-4-酮衍生物的合成、分子对接及其抗惊厥活性评估
Cent Nerv Syst Agents Med Chem. 2018 Jan 26;18(1):63-73. doi: 10.2174/1871524917666170104142033.
5
Synthesis and anticonvulsant activity of acetylenic quinazolinone derivatives.炔基喹唑啉酮衍生物的合成及其抗惊厥活性
Arch Pharm (Weinheim). 2000 Aug;333(8):261-6.
6
Design and synthesis of some new quinazolin-4-(3H)-ones as anticonvulsant and antidepressant agents.设计和合成一些新型的喹唑啉-4-(3H)-酮类化合物作为抗惊厥和抗抑郁药物。
Arch Pharm Res. 2013 Jan;36(1):61-8. doi: 10.1007/s12272-013-0004-y.
7
Synthesis, In Vivo Anticonvulsant Activity Evaluation and In Silico Studies of Some Quinazolin-4(3H)-One Derivatives.合成、体内抗惊厥活性评价及部分喹唑啉-4(3H)-酮衍生物的计算机辅助研究。
Molecules. 2024 Apr 24;29(9):1951. doi: 10.3390/molecules29091951.
8
Synthesis and anticonvulsant activity evaluation of 5-phenyl-[1,2,4]triazolo[4,3-c]quinazolin-3-amines.5-苯基-[1,2,4]三唑并[4,3-c]喹唑啉-3-胺的合成及抗惊厥活性评价。
Arch Pharm (Weinheim). 2013 Feb;346(2):119-26. doi: 10.1002/ardp.201200376. Epub 2012 Dec 18.
9
CNS depressant and anticonvulsant activities of some novel 3-[5-substituted 1,3,4-thiadiazole-2-yl]-2-styryl quinazoline-4(3H)-ones.某些新型3-[5-取代的1,3,4-噻二唑-2-基]-2-苯乙烯基喹唑啉-4(3H)-酮的中枢神经系统抑制和抗惊厥活性
Eur J Med Chem. 2008 Sep;43(9):1945-54. doi: 10.1016/j.ejmech.2007.12.003. Epub 2007 Dec 23.
10
Synthesis, anticonvulsant activity and molecular modeling study of some new hydrazinecarbothioamide, benzenesulfonohydrazide, and phenacylacetohydrazide analogues of 4(3H)-quinazolinone.
Bioorg Med Chem Lett. 2015 Apr 1;25(7):1490-9. doi: 10.1016/j.bmcl.2015.02.025. Epub 2015 Feb 20.

引用本文的文献

1
Benzimidazole as a Privileged Scaffold in Drug Design and Discovery.苯并咪唑作为药物设计和发现中的优势骨架。
Curr Top Med Chem. 2024;24(17):1504-1528. doi: 10.2174/0115680266314704240522112439.
2
Synthesis, In Vivo Anticonvulsant Activity Evaluation and In Silico Studies of Some Quinazolin-4(3H)-One Derivatives.合成、体内抗惊厥活性评价及部分喹唑啉-4(3H)-酮衍生物的计算机辅助研究。
Molecules. 2024 Apr 24;29(9):1951. doi: 10.3390/molecules29091951.
3
Schiff Bases: A Captivating Scaffold with Potential Anticonvulsant Activity.席夫碱:一种具有潜在抗惊厥活性的迷人支架。

本文引用的文献

1
Synthesis and anticancer activity of new quinazoline derivatives.新型喹唑啉衍生物的合成及其抗癌活性
Saudi Pharm J. 2017 Nov;25(7):1047-1054. doi: 10.1016/j.jsps.2017.04.022. Epub 2017 Apr 22.
2
Synthesis, Modelling, and Anticonvulsant Studies of New Quinazolines Showing Three Highly Active Compounds with Low Toxicity and High Affinity to the GABA-A Receptor.新型喹唑啉的合成、建模及抗惊厥研究:三种具有低毒性和对GABA-A受体高亲和力的高活性化合物
Molecules. 2017 Jan 24;22(2):188. doi: 10.3390/molecules22020188.
3
Synthesis and Pharmacological Evaluation of New 3,4-Dihydroisoquinolin Derivatives Containing Heterocycle as Potential Anticonvulsant Agents.
Mini Rev Med Chem. 2024;24(18):1632-1650. doi: 10.2174/0113895575302197240408121537.
4
and Evaluation of Anticholinesterase and Antidiabetic Effects of Furanolabdanes and Other Constituents from (Linn.) Griffith.呋喃甾体烷和其他成分的抗胆碱酯酶和抗糖尿病作用的评价。
Molecules. 2023 Jun 16;28(12):4802. doi: 10.3390/molecules28124802.
5
Biologically potent organotin(iv) complexes of -acetylated β-amino acids with spectroscopic, X-ray powder diffraction and molecular docking studies.具有光谱、X射线粉末衍射和分子对接研究的生物活性有机锡(IV)-乙酰化β-氨基酸配合物。
RSC Adv. 2023 Apr 5;13(16):10768-10789. doi: 10.1039/d2ra06718h. eCollection 2023 Apr 3.
6
Quinazolinones, the Winning Horse in Drug Discovery.喹唑酮,药物研发的制胜之选。
Molecules. 2023 Jan 18;28(3):978. doi: 10.3390/molecules28030978.
7
Significant pharmacological activities of benzoquinazolines scaffold.苯并喹唑啉类支架的重要药理学活性。
Pharmacol Rep. 2023 Apr;75(2):223-235. doi: 10.1007/s43440-023-00453-9. Epub 2023 Feb 6.
8
One-pot regioselective C-H activation iodination-cyanation of 2,4-diarylquinazolines using malononitrile as a cyano source.以丙二腈为氰基源一锅法实现2,4-二芳基喹唑啉的区域选择性C-H活化碘化-氰化反应
RSC Adv. 2019 Jun 11;9(32):18256-18264. doi: 10.1039/c9ra02979f. eCollection 2019 Jun 10.
9
Sunflower-Assisted Bio-Derived ZnO-NPs as an Efficient Nanocatalyst for the Synthesis of Novel Quinazolines with Highly Antioxidant Activities.向日葵辅助生物衍生的氧化锌纳米粒子作为一种高效的纳米催化剂用于合成具有高抗氧化活性的新型喹唑啉类化合物。
Antioxidants (Basel). 2022 Mar 31;11(4):688. doi: 10.3390/antiox11040688.
10
Novel 3-chloro-6-nitro-1-indazole derivatives as promising antileishmanial candidates: synthesis, biological activity, and molecular modelling studies.新型 3-氯-6-硝基-1-吲唑衍生物作为有前途的抗利什曼原虫候选物:合成、生物活性和分子模拟研究。
J Enzyme Inhib Med Chem. 2022 Dec;37(1):151-167. doi: 10.1080/14756366.2021.1995380.
含杂环新型3,4-二氢异喹啉衍生物作为潜在抗惊厥剂的合成与药理评价
Molecules. 2016 Nov 29;21(12):1635. doi: 10.3390/molecules21121635.
4
Coumarin or benzoxazinone based novel carbonic anhydrase inhibitors: synthesis, molecular docking and anticonvulsant studies.基于香豆素或苯并恶嗪酮的新型碳酸酐酶抑制剂:合成、分子对接及抗惊厥研究
J Enzyme Inhib Med Chem. 2016 Oct;31(5):760-72. doi: 10.3109/14756366.2015.1063624. Epub 2015 Jul 24.
5
Design, synthesis and biological evaluation of new hybrid anticonvulsants derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide derivatives.源自N-苄基-2-(2,5-二氧代吡咯烷-1-基)丙酰胺和2-(2,5-二氧代吡咯烷-1-基)丁酰胺衍生物的新型杂合抗惊厥药的设计、合成及生物学评价
Bioorg Med Chem. 2015 May 15;23(10):2548-61. doi: 10.1016/j.bmc.2015.03.038. Epub 2015 Mar 21.
6
Synthesis, anticonvulsant activity and molecular modeling study of some new hydrazinecarbothioamide, benzenesulfonohydrazide, and phenacylacetohydrazide analogues of 4(3H)-quinazolinone.
Bioorg Med Chem Lett. 2015 Apr 1;25(7):1490-9. doi: 10.1016/j.bmcl.2015.02.025. Epub 2015 Feb 20.
7
Out of the active site binding pocket for carbonic anhydrase inhibitors.在碳酸酐酶抑制剂的活性位点结合口袋之外。
Chem Commun (Camb). 2015;51(2):302-5. doi: 10.1039/c4cc07320g.
8
Quinazoline-sulfonamides with potent inhibitory activity against the α-carbonic anhydrase from Vibrio cholerae.对霍乱弧菌α-碳酸酐酶具有强效抑制活性的喹唑啉-磺酰胺类化合物。
Bioorg Med Chem. 2014 Oct 1;22(19):5133-40. doi: 10.1016/j.bmc.2014.08.015. Epub 2014 Aug 21.
9
Neuroactive peptides as putative mediators of antiepileptic ketogenic diets.神经活性肽作为抗癫痫生酮饮食的潜在介质。
Front Neurol. 2014 Apr 29;5:63. doi: 10.3389/fneur.2014.00063. eCollection 2014.
10
Structure-based drug discovery of carbonic anhydrase inhibitors.基于结构的碳酸酐酶抑制剂药物研发。
J Enzyme Inhib Med Chem. 2012 Dec;27(6):759-72. doi: 10.3109/14756366.2012.672983. Epub 2012 Apr 2.